Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-22

Clinical Trial Update: Efficacy of Spironolactone Combined With Antihypertensive Drugs in Patients With Primary Aldosteronism

View source ↗

Summary

A clinical trial evaluating whether spironolactone together with other antihypertensive medications improves outcomes in patients with primary aldosteronism, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

Sponsor: Third Military Medical University | Conditions: Primary Aldosteronism, Hypertension | Status: RECRUITING